Literature DB >> 14711395

Determining appropriate substrate conversion for enzymatic assays in high-throughput screening.

Ge Wu1, Yue Yuan, C Nicholas Hodge.   

Abstract

It is generally accepted that the conversion of substrate should be kept at less than 10% of the total substrate used when studying enzyme kinetics. However, 10% or less substrate conversion often will not produce sufficient signal changes required for robust high-throughput screening (HTS). To increase the signal-to-background ratio, HTS is often performed at higher than 10% substrate conversion. Because the consequences of high substrate conversion are poorly understood, the screening results are sometimes questioned by enzymologists. The quality of an assay is judged by the ability to detect an inhibitor under HTS conditions, which depends on the robustness of the primary detection signal (Z factor) and the sensitivity to an inhibitor. The assay sensitivity to an inhibitor is reflected in the observed IC(50) value or percent inhibition at a fixed compound concentration when single-point data are collected. The major concern for an enzymatic assay under high substrate conversion is that the sensitivity of the screen may be compromised. Here we derive the relationship between the IC(50) value for a given inhibitor and the percentage of substrate conversion using a first-order kinetic model under conditions that obey Henri-Michaelis-Menten kinetics. The derived theory was further verified experimentally with a cAMP-dependent protein kinase. This model provides guidance for assay developers to choose an appropriate substrate conversion in designing an enzymatic assay, balancing the needs for robust signal and sensitivity to inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711395     DOI: 10.1177/1087057103260050

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  14 in total

1.  Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors.

Authors:  Guangping Dong; Adam Yasgar; Darrell L Peterson; Alexey Zakharov; Daniel Talley; Ken Chih-Chien Cheng; Ajit Jadhav; Anton Simeonov; Rong Huang
Journal:  ACS Comb Sci       Date:  2020-06-27       Impact factor: 3.784

2.  Comparison of bioluminescent kinase assays using substrate depletion and product formation.

Authors:  Cordelle Tanega; Min Shen; Bryan T Mott; Craig J Thomas; Ryan MacArthur; James Inglese; Douglas S Auld
Journal:  Assay Drug Dev Technol       Date:  2009-12       Impact factor: 1.738

3.  Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).

Authors:  Mark R Swingle; Richard E Honkanen
Journal:  Assay Drug Dev Technol       Date:  2014-10       Impact factor: 1.738

4.  A homogeneous resonance energy transfer assay for phosphopantetheinyl transferase.

Authors:  Timothy L Foley; Michael D Burkart
Journal:  Anal Biochem       Date:  2009-06-30       Impact factor: 3.365

5.  Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay.

Authors:  Christophe Marchand; Wendy A Lea; Ajit Jadhav; Thomas S Dexheimer; Christopher P Austin; James Inglese; Yves Pommier; Anton Simeonov
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

6.  High-throughput screening for human galactokinase inhibitors.

Authors:  Klaas J Wierenga; Kent Lai; Peter Buchwald; Manshu Tang
Journal:  J Biomol Screen       Date:  2008-05-19

7.  Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.

Authors:  Laura Pedró-Rosa; Frederick S Buckner; Ranae M Ranade; Christina Eberhart; Franck Madoux; J Robert Gillespie; Cho Yeow Koh; Steven Brown; Jacqueline Lohse; Christophe L M Verlinde; Erkang Fan; Thomas Bannister; Louis Scampavia; Wim G J Hol; Timothy Spicer; Peter Hodder
Journal:  J Biomol Screen       Date:  2014-08-27

8.  Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.

Authors:  Mindy I Davis; Douglas S Auld; James Inglese
Journal:  Methods Mol Biol       Date:  2016

9.  Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor.

Authors:  Ruth X Wang; Morkos A Henen; J Scott Lee; Beat Vögeli; Sean P Colgan
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Improved inhibitor screening experiments by comparative analysis of simulated enzyme progress curves.

Authors:  Fredrik Tholander
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.